Health
Synairgen boss says SNG001 results “a clearer signal than we could have dared hope for” – Proactive Investors UK
On Monday, the company reported that patients who received its treatment had a 79% lower risk of developing severe disease compared to those given the placebo
On Monday, the company reported that patients who received its treatment had a 79% lower risk of developing severe disease compared to those given the placeboSynairgen PLCs (LON:SNG) chief executive Richard Marsden has said that the results from the companys latest trial of its SNG001 treatment for coronavirus are a clearer signal then we could have dared to hope for.
On Monday, the company reported that patients who received SNG001, an inhaled formulation of interferon beta, had a 79% lower ri…
-
General23 hours agoKim Kardashian not deterred by bar failure
-
Business18 hours agoMacquarie tips more than 20% upside for this ASX mining stock
-
Noosa News16 hours agoSchools ban e-bikes | Noosa Today
-
Noosa News15 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub